Elevated cDPP3 in acute heart failure identified a distinct clinical phenotype but was not associated with adverse clinical outcomes or congestion relief during GDMT optimization.
Does elevated cDPP3 predict adverse clinical outcomes or congestion relief in patients with acute heart failure during GDMT optimization?
Elevated cDPP3 identifies a distinct clinical phenotype in acute heart failure but does not predict adverse clinical outcomes or congestion relief during GDMT optimization.
Absolute Event Rate: 0% vs 0%
In AHF, cDPP3 was mildly elevated and was not associated with clinical outcomes or congestion relief during GDMT optimization. Elevated cDPP3 identified a distinct clinical phenotype but did not confer adverse prognosis.
Bruno et al. (Sat,) reported a other. Elevated cDPP3 in acute heart failure identified a distinct clinical phenotype but was not associated with adverse clinical outcomes or congestion relief during GDMT optimization.